Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An announcement from Diagnostic Medical Systems ( (FR:ALDMS) ) is now available.
DMS Group announced a videoconference for shareholders and individual investors to be held on January 16, 2025, coinciding with the release of its 2024 annual revenue. The event, which requires prior registration, will feature presentations by the company’s Chairman and CEO, as well as the Administrative and Financial Director, who will discuss the company’s activities over the past fiscal year and answer live questions. This initiative reflects DMS Group’s commitment to transparency and engagement with its investors.
More about Diagnostic Medical Systems
DMS Group is a French company specializing in high-performance medical imaging systems, particularly in digital radiology and osteodensitometry. With an international presence through a network of over 140 national distributors, the company achieved a consolidated revenue of €42.2 million in 2023, with 75% generated internationally. DMS Group is listed on the Euronext Growth Paris market and is part of the ETIncelles program.
YTD Price Performance: 9.35%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €14.48M
See more insights into ALDMS stock on TipRanks’ Stock Analysis page.
